Loading clinical trials...
Loading clinical trials...
Do 'Known' QT-prolonging Medications Cause Major Adverse Cardiac Events in Hospitalized Adults? The QTP-MACE Study
Conditions
Locations
2
Canada
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada
GEMINI
Toronto, Ontario, Canada
Start Date
February 1, 2025
Primary Completion Date
December 1, 2027
Completion Date
December 1, 2027
Last Updated
January 28, 2026
NCT06835491
NCT07103733
NCT06747013
NCT04394637
NCT03833089
NCT02864771
Lead Sponsor
St. Joseph's Healthcare Hamilton
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions